Llwytho...
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s. However, MM was first-in line to benefit from the wave of checkpoint inhibitors (CPI), which shifted the focus of immunotherapy al...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Immunother Cancer |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398110/ https://ncbi.nlm.nih.gov/pubmed/32747469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000668 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|